CRS group | Emmetropia group | P value | |
---|---|---|---|
Age (years): | 30.33 ± 4.60 (23–35) | 29.64 ± 3.77 (23–35) | 0.296 |
Gender (M/F): | 106/2 | 98/1 | 0.533 |
Spherical equivalent (D): | −0.023 ± 0.52 | 0.023 ± 0.30 | 0.268 |
Diagnosis: | |||
ADs and BDs | 17 (15.7%) | 15 (15.2) | 0.524 |
Asymptomatic CI | 8 (7.41%) | 7 (7.07%) | 0.570 |
NBV subjects | 83 (76.85%) | 77 (77.78%) | – |
Total | 108 (100%) | 99 (100%) | – |
Clinical findings | |||
AA (right eye only, D) | 9.65 ± 2.06 | 9.27 ± 1.78 | 0.206 |
MAF (right eye only, cpm) | 12.81 ± 6.93 | 11.80 ± 6.64 | 0.434 |
BAF (cpm) | 12.41 ± 6.44 | 10.73 ± 5.79 | 0.068 |
MEM (right eye only, D) | −0.076 ± 0.55 | −0.025 ± 0.50 | 0.494 |
PRA (D) | −2.66 ± 1.49 | −2.35 ± 1.37 | 0.122 |
NRA (D) | 1.87 ± 0.60 | 1.73 ± 0.60 | 0.136 |
Phoria (Δ) | |||
Near | −3.73 ± 4.94 | −3.59 ± 5.32 | 0.505 |
Distance | −1.56 ± 2.51 | −1.53 ± 2.63 | 0.481 |
PFV (Near break point) (Δ) | 23.00 ± 7.72 | 22.37 ± 7.72 | 0.468 |
NFV (Near break point) (Δ) | 20.53 ± 5.39 | 19.89 ± 4.81 | 0.246 |